Saudi Arabia’s Imam Abdulrahman Bin Faisal University started the first phase of clinical trials to produce the Covid-19 vaccine, state-run Saudi Press Agency (SPA) reported.
The step, supported by the Ministry of Education, comes after the university had completed the laboratory experiments and proved their efficacy, reflecting the contribution of Saudi universities and their integration with the national efforts aimed at producing the first Saudi vaccine against the coronavirus.
The university struck a deal with one of the largest specialized companies in the UK and Sweden and worked with leading companies in the production of vaccines and medicines such as AstraZeneca to create appropriate quantities for use in the first phase of clinical trials.
In addition, it signed a contract with a Center specialized in conducting clinical trials to collaborate with the university’s research team in preparing and supervising the clinical stage protocol.
The university had also cooperated with an office specialized in documenting and registering intellectual property rights for the project.